Recent Updates
Recently added Catalysts
IDXX Neutral Sentiment

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Key Takeaway: IDEXX Laboratories is set to announce its financial results for the second quarter of 2026. The release will provide insights into the company's performance and financial health during this period. Investors and stakeholders are likely to closely monitor these results for future guidance.
Price reaction · baseline $537.58 (2026-07-01 close) · hit after-hours · clean, no other IDXX news in the window
day 0 close · peak
+3.8%

Market Sentiment Analysis

Full Press Release Details

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc.(NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX website,www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-330-6730 or 1-213-279-1575 and reference passcode 922025.

2026 Investor Day

IDEXX Laboratories, Inc. will host its 2026 Investor Day on Thursday, August 13, 2026, at its corporate headquarters in Westbrook, Maine from 8:00 am to approximately 12:00 pm ET. A live webcast of the presentations will be available onwww.idexx.com/investors. Advance registration for the in-person event is required; institutional investors and analysts interested in attending should contactinvestorrelations@idexx.com. Additional information on IDEXX’s Investor Day will be provided closer to the date of the event.

About IDEXX Laboratories, Inc.

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500®Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visitwww.idexx.com.
Last updated: Jul 1, 2026